These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38834351)

  • 1. Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies.
    Dubreuil M; Navarro-Compán V; Boonen A; Gaffney K; Gensler LS; de la Loge C; Vaux T; Fleurinck C; Massow U; Taieb V; Mørup MF; Deodhar A; Rudwaleit M
    RMD Open; 2024 Jun; 10(2):. PubMed ID: 38834351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trial.
    Ramiro S; Lukas C; Nissen MJ; Zhu B; Ng KJ; Sheesh M; Doridot G; Liu-Leage S; Chan A; Fang Y; Wei JC
    Semin Arthritis Rheum; 2024 Dec; 69():152571. PubMed ID: 39509838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.
    Baraliakos X; de Jongh J; Poddubnyy D; Zwezerijnen GJC; Hemke R; Glatt S; Shaw S; Ionescu L; El Baghdady A; Mann J; Maguire RP; Vaux T; de Peyrecave N; Oortgiesen M; Baeten D; van der Laken C
    Ther Adv Musculoskelet Dis; 2024; 16():1759720X241293944. PubMed ID: 39620046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies.
    Husni ME; Mease PJ; Merola JF; Tillett W; Goldammer N; Ink B; Coarse J; Lambert J; Taieb V; Gladman DD
    RMD Open; 2024 Sep; 10(3):. PubMed ID: 39313302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
    Christiansen SN; Horskjær Rasmussen S; Ostergaard M; Pons M; Michelsen B; Pavelka K; Codreanu C; Ciurea A; Glintborg B; Santos MJ; Sari I; Rotar Z; Gudbjornsson B; Macfarlane GJ; Relas H; Iannone F; Laas K; Wallman JK; van de Sande M; Provan SA; Castrejon I; Zavada J; Mogosan C; Nissen MJ; Loft AG; Barcelos A; Erez Y; Pirkmajer KP; Grondal G; Jones GT; Hokkanen AM; Chimenti MS; Vorobjov S; Di Giuseppe D; Kvien TK; Otero-Varela L; van der Horst-Bruinsma I; Hetland ML; Ørnbjerg LM
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39053949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease.
    Kishnani PS; Byrne BJ; Claeys KG; Díaz-Manera J; Dimachkie MM; Kushlaf H; Mozaffar T; Roberts M; Schoser B; Hummel N; Kopiec A; Holdbrook F; Shohet S; Toscano A;
    J Patient Rep Outcomes; 2024 Nov; 8(1):132. PubMed ID: 39535661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally Invasive Transforaminal Versus Lateral Lumbar Interbody Fusion for Degenerative Spinal Pathology: Clinical Outcome Comparison in Patients With Predominant Back Pain.
    Jacob KC; Patel MR; Hartman TJ; Nie JW; Parsons AW; Ribot MA; Prabhu M; Pawlowski H; Vanjani N; Singh K
    Clin Spine Surg; 2024 Dec; 37(10):E441-E447. PubMed ID: 39450893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between emotional state, sleep disturbance and health-related quality of life in patients with axial spondyloarthritis.
    Cai Y; Chen J; Dou J; Zhou N; Shao H; Shen X; Hong M; Chen J; Fan X; Hu Q; Lu C
    Clin Rheumatol; 2024 Nov; ():. PubMed ID: 39609324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study.
    Baraliakos X; van der Heijde D; Sieper J; Inman RD; Kameda H; Maksymowych WP; Lagunes-Galindo I; Bu X; Wung P; Kato K; Shmagel A; Deodhar A
    Arthritis Res Ther; 2024 Nov; 26(1):197. PubMed ID: 39533349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status.
    Rudwaleit M; Deodhar A; Bauer L; Gensler L; Hoepken B; Kumke T; Auteri SE; Kim M; Maksymowych W
    RMD Open; 2024 May; 10(2):. PubMed ID: 38724259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled Trials.
    Merola JF; Gottlieb AB; Pinter A; Elewski B; Gooderham M; Warren RB; Piaserico S; Wixted K; Cross N; Tilt N; Wiegratz S; Mrowietz U
    Dermatol Ther (Heidelb); 2024 Dec; 14(12):3291-3306. PubMed ID: 39578348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
    Vermeire S; Schreiber S; Rubin DT; D'Haens G; Reinisch W; Watanabe M; Mehta R; Roblin X; Beales I; Gietka P; Hibi T; Hospodarskyy I; Ritter T; Genovese MC; Kwon P; Santermans E; Le Brun FO; Barron R; Masior T; Danese S
    Lancet Gastroenterol Hepatol; 2024 Dec; ():. PubMed ID: 39637881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo.
    Sampson E; Mills NT; Hori H; Cearns M; Schwarte K; Hohoff C; Oliver Schubert K; Fourrier C; Baune BT
    Brain Behav Immun; 2025 Jan; 123():43-56. PubMed ID: 39243988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis.
    Ramiro S; Lukas C; Bessette L; Wickersham P; Panni T; Bolce R; Liu-Leage S; Janos B; Nissen MJ; Wei JC
    RMD Open; 2024 Jul; 10(3):. PubMed ID: 39004432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.